Moderna, Inc. stock is up ~60% YTD on cancer vaccine trial data, 2026 readouts, and 2025 financials. Click for this updated ...
Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary Robert F. Kennedy, Jr.'s announcement ending federal support for mRNA ...
mRNA Synthesis and Manufacturing Market to Witness a Leap by Leaching CAGR of ~6% By The End Of 2030
Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...
Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy, and broad ...
In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results